Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,740
+50 (0.37%)
Last updated: Aug 12, 2025

KRX:271980 Revenue

Jeil Pharmaceutical Co.,Ltd had revenue of 163.02B KRW in the quarter ending March 31, 2025, a decrease of -4.34%. This brings the company's revenue in the last twelve months to 697.15B, down -1.22% year-over-year. In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B, down -3.01%.

Revenue (ttm)
697.15B
Revenue Growth
-1.22%
P/S Ratio
0.29
Revenue / Employee
739.29M
Employees
943
Market Cap
204.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024704.54B-21.85B-3.01%
Dec 31, 2023726.39B4.16B0.58%
Dec 31, 2022722.23B21.54B3.07%
Dec 31, 2021700.69B9.37B1.36%
Dec 31, 2020691.32B19.92B2.97%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
Peptron4.30B
PharmaResearch392.31B
LigaChem Biosciences146.42B
Revenue Rankings